Trial Profile
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder; Overactive bladder
- Focus Therapeutic Use
- Acronyms BOT-SCI
- 22 Nov 2022 Status changed from active, no longer recruiting to completed.
- 29 Dec 2020 Planned End Date changed from 1 Dec 2020 to 20 Dec 2020.
- 29 Dec 2020 Planned primary completion date changed from 6 Oct 2020 to 20 Dec 2020.